-
1
-
-
53249090182
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
-
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008; 29: 2388-2442.
-
(2008)
Eur Heart J
, vol.29
, pp. 2388-2442
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
McMurray, J.J.4
Ponikowski, P.5
Poole-Wilson, P.A.6
-
2
-
-
0017315924
-
Effect of xanthine oxidase inhibitor on myocardial ischemia
-
Minaga T, Takeda K, Nakamura T, Kizu A, Ijichi H. Effect of xanthine oxidase inhibitor on myocardial ischemia. RecentAdv Stud Cardiac Struct Metab 1976; 11: 555-558.
-
(1976)
RecentAdv Stud Cardiac Struct Metab
, vol.11
, pp. 555-558
-
-
Minaga, T.1
Takeda, K.2
Nakamura, T.3
Kizu, A.4
Ijichi, H.5
-
3
-
-
0037155054
-
Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart
-
Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 2002; 90: 297-304.
-
(2002)
Circ Res
, vol.90
, pp. 297-304
-
-
Saavedra, W.F.1
Paolocci, N.2
John, S.M.E.3
Skaf, M.W.4
Stewart, G.C.5
Xie, J.S.6
-
4
-
-
0035814786
-
Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing induced heart failure
-
Ukai T, Cheng CP, Tachibana H, Igawa A, Zhang ZS, Cheng HJ, et al. Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing induced heart failure. Circulation 2001; 103: 750-755.
-
(2001)
Circulation
, vol.103
, pp. 750-755
-
-
Ukai, T.1
Cheng, C.P.2
Tachibana, H.3
Igawa, A.4
Zhang, Z.S.5
Cheng, H.J.6
-
5
-
-
0033520357
-
Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing induced heart failure
-
Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing induced heart failure. Circ Res 1999; 5: 437-445.
-
(1999)
Circ Res
, vol.5
, pp. 437-445
-
-
Ekelund, U.E.1
Harrison, R.W.2
Shokek, O.3
Thakkar, R.N.4
Tunin, R.S.5
Senzaki, H.6
-
6
-
-
0035856508
-
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
-
Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 20: 2407-2411.
-
(2001)
Circulation
, vol.20
, pp. 2407-2411
-
-
Cappola, T.P.1
Kass, D.A.2
Nelson, G.S.3
Berger, R.D.4
Rosas, G.O.5
Kobeissi, Z.A.6
-
7
-
-
23644437342
-
Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure
-
Amado LC, Saliaris AP, Raju SV, Lehrke S, St John M, Xie J, et al. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol 2005; 3: 531-536.
-
(2005)
J Mol Cell Cardiol
, vol.3
, pp. 531-536
-
-
Amado, L.C.1
Saliaris, A.P.2
Raju, S.V.3
Lehrke, S.4
John, S.M.5
Xie, J.6
-
8
-
-
20844461656
-
Allopurinol attenuates leftventricular remodeling and dysfunction after experimental myocardial infarction: A new action for an old drug?
-
Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, et al. Allopurinol attenuates leftventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug? Circulation 2004; 15: 2175-2179.
-
(2004)
Circulation
, vol.15
, pp. 2175-2179
-
-
Engberding, N.1
Spiekermann, S.2
Schaefer, A.3
Heineke, A.4
Wiencke, A.5
Muller, M.6
-
9
-
-
33644619835
-
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts
-
Naumova AV, Chacko VP, Ouwerkerk R, Stull L, Marban E, Weiss RG. Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts. Am J Physiol Heart Circ Physiol 2006; 2: H837-H843.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.2
-
-
Naumova, A.V.1
Chacko, V.P.2
Ouwerkerk, R.3
Stull, L.4
Marban, E.5
Weiss, R.G.6
-
10
-
-
33644630969
-
Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy
-
Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, et al. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 2006; 2: 271-279.
-
(2006)
Circ Res
, vol.2
, pp. 271-279
-
-
Minhas, K.M.1
Saraiva, R.M.2
Schuleri, K.H.3
Lehrke, S.4
Zheng, M.5
Saliaris, A.P.6
-
11
-
-
28944437578
-
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
-
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450-2461.
-
(2005)
N Engl J Med
, vol.353
, pp. 2450-2461
-
-
Becker, M.A.1
Schumacher Jr., H.R.2
Wortmann, R.L.3
Macdonald, P.A.4
Eustace, D.5
Palo, W.A.6
-
12
-
-
1642484244
-
Xanthine oxidoreductase and cardiovascular disease-molecular mechanisms andpathophysiologic implications
-
Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease-molecular mechanisms andpathophysiologic implications. J Physiol 2004; 555: 589-606.
-
(2004)
J Physiol
, vol.555
, pp. 589-606
-
-
Berry, C.E.1
Hare, J.M.2
-
13
-
-
9544229815
-
Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31P-MRS study
-
Zhang J, Wilke N, Wang Y, Zhang Y, Wang C, Eijgelshoven MH, et al. Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31P-MRS study. Circulation 1996; 94: 1089-1100.
-
(1996)
Circulation
, vol.94
, pp. 1089-1100
-
-
Zhang, J.1
Wilke, N.2
Wang, Y.3
Zhang, Y.4
Wang, C.5
Eijgelshoven, M.H.6
-
14
-
-
0030819144
-
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy
-
Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190-2196.
-
(1997)
Circulation
, vol.96
, pp. 2190-2196
-
-
Neubauer, S.1
Horn, M.2
Cramer, M.3
Harre, K.4
Newell, J.B.5
Peters, W.6
-
15
-
-
18244379331
-
Superoxide activates mitochondrial uncoupling proteins
-
Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA, et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002; 415: 96-99.
-
(2002)
Nature
, vol.415
, pp. 96-99
-
-
Echtay, K.S.1
Roussel, D.2
St-Pierre, J.3
Jekabsons, M.B.4
Cadenas, S.5
Stuart, J.A.6
-
16
-
-
0037905740
-
2 regulates cardiac myocyte phenotype viaconcentration-dependent activation of distinct kinase pathways
-
Kwon SH, Pimentel DR, Remondino A, Sawyer DB, Colucci WS. H2O2 regulates cardiac myocyte phenotype viaconcentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 2003; 35: 615-621.
-
(2003)
J Mol Cell Cardiol
, vol.35
, pp. 615-621
-
-
Kwon, S.H.1
Pimentel, D.R.2
Remondino, A.3
Sawyer, D.B.4
Colucci, W.S.5
-
17
-
-
0036791698
-
Activation of NADPH oxidase during progression of cardiac hypertrophy tofailure
-
Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy tofailure. Hypertension 2002; 40: 477-484.
-
(2002)
Hypertension
, vol.40
, pp. 477-484
-
-
Li, J.M.1
Gall, N.P.2
Grieve, D.J.3
Chen, M.4
Shah, A.M.5
-
18
-
-
0037028866
-
The antioxidant N-2-mercaptopropionylglycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model
-
Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, et al. The antioxidant N-2-mercaptopropionylglycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 2002; 39: 907-912.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 907-912
-
-
Date, M.O.1
Morita, T.2
Yamashita, N.3
Nishida, K.4
Yamaguchi, O.5
Higuchi, Y.6
-
19
-
-
0036487320
-
Involvement of reactive oxygenspecies-mediated NF-kappa B activation in TNF-alphainduced cardiomyocyte hypertrophy
-
Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, Yamaguchi O, et al. Involvement of reactive oxygenspecies-mediated NF-kappa B activation in TNF-alphainduced cardiomyocyte hypertrophy. J Mol Cell Cardiol 2002; 34: 233-240.
-
(2002)
J Mol Cell Cardiol
, vol.34
, pp. 233-240
-
-
Higuchi, Y.1
Otsu, K.2
Nishida, K.3
Hirotani, S.4
Nakayama, H.5
Yamaguchi, O.6
-
20
-
-
0035980171
-
Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes
-
Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, et al. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001; 89: 453-460.
-
(2001)
Circ Res
, vol.89
, pp. 453-460
-
-
Pimentel, D.R.1
Amin, J.K.2
Xiao, L.3
Miller, T.4
Viereck, J.5
Oliver-Krasinski, J.6
-
22
-
-
0037969707
-
ASK1 associates with troponin T and induces troponin Tphosphorylation and contractile dysfunction incardiomyocytes
-
He X, Liu Y, Sharma V, Dirksen RT, Waugh R, Sheu SS, et al. ASK1 associates with troponin T and induces troponin Tphosphorylation and contractile dysfunction incardiomyocytes. Am J Pathol 2003; 163: 243-251.
-
(2003)
Am J Pathol
, vol.163
, pp. 243-251
-
-
He, X.1
Liu, Y.2
Sharma, V.3
Dirksen, R.T.4
Waugh, R.5
Sheu, S.S.6
-
23
-
-
14644442283
-
Oxygen, oxidative stress, hypoxia, and heart failure
-
Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500-508.
-
(2005)
J Clin Invest
, vol.115
, pp. 500-508
-
-
Giordano, F.J.1
-
24
-
-
2342427941
-
Oxidative stress during myocardial ischaemia and heart failure
-
Ferrari R, Guardigli G, Mele D, Percoco GF, Ceconi C, Curello S. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des 2004; 10: 1699-1711.
-
(2004)
Curr Pharm Des
, vol.10
, pp. 1699-1711
-
-
Ferrari, R.1
Guardigli, G.2
Mele, D.3
Percoco, G.F.4
Ceconi, C.5
Curello, S.6
-
28
-
-
0032574631
-
Elevated levels of 8-iso-prostaglandin F2alpha in pericardialfluid of patients with heart failure: A potential role for in vivooxidant stress in ventricular dilatation and progression to heart failure
-
Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardialfluid of patients with heart failure: a potential role for in vivooxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998; 97: 1536-1539.
-
(1998)
Circulation
, vol.97
, pp. 1536-1539
-
-
Mallat, Z.1
Philip, I.2
Lebret, M.3
Chatel, D.4
Maclouf, J.5
Tedgui, A.6
-
29
-
-
0345258510
-
Regulation of hypertrophicand apoptotic signaling pathways by reactive oxygen species in cardiac myocytes
-
Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophicand apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal 2003; 5: 731-740.
-
(2003)
Antioxid Redox Signal
, vol.5
, pp. 731-740
-
-
Sabri, A.1
Hughie, H.H.2
Lucchesi, P.A.3
-
30
-
-
0033001511
-
Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rathearts
-
Ferdinandy P, Panas D, Schulz R. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rathearts. Am J Physiol 1999; 276: H1861-H1867.
-
(1999)
Am J Physiol
, vol.276
-
-
Ferdinandy, P.1
Panas, D.2
Schulz, R.3
-
31
-
-
0033900011
-
Peroxynitrite is a major contributor to cytokine-inducedmyocardial contractile failure
-
Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-inducedmyocardial contractile failure. Circ Res 2000; 87: 241-247.
-
(2000)
Circ Res
, vol.87
, pp. 241-247
-
-
Ferdinandy, P.1
Danial, H.2
Ambrus, I.3
Rothery, R.A.4
Schulz, R.5
-
32
-
-
0037155054
-
Imbalance between xanthine oxidase and nitricoxide synthase signaling pathways underlies mechano-energetic uncoupling in the failing heart
-
Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, et al. Imbalance between xanthine oxidase and nitricoxide synthase signaling pathways underlies mechano-energetic uncoupling in the failing heart. Circ Res. 2002; 90: 297-304.
-
(2002)
Circ Res
, vol.90
, pp. 297-304
-
-
Saavedra, W.F.1
Paolocci, N.2
John, S.M.E.3
Skaf, M.W.4
Stewart, G.C.5
Xie, J.S.6
-
33
-
-
0033749842
-
Enhanced expression and activity of xanthine oxidoreductase in the failing heart
-
de Jong JW, Schoemaker RG, de Jonge R, Bernocchi P, Keijzer E, Harrison R, et al. Enhanced expression and activity of xanthine oxidoreductase in the failing heart. J Mol Cell Cardiol 2000; 32: 2083-2089.
-
(2000)
J Mol Cell Cardiol
, vol.32
, pp. 2083-2089
-
-
de Jong, J.W.1
Schoemaker, R.G.2
de Jonge, R.3
Bernocchi, P.4
Keijzer, E.5
Harrison, R.6
-
34
-
-
0032402381
-
Uric acid in chronic heart failure: A marker of chronic inflammation
-
Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 1998; 19: 1814-1822.
-
(1998)
Eur Heart J
, vol.19
, pp. 1814-1822
-
-
Leyva, F.1
Anker, S.D.2
Godsland, I.F.3
Teixeira, M.4
Hellewell, P.G.5
Kox, W.J.6
-
35
-
-
8844261207
-
Chronic treatment with allopurinol boosts survival and cardiaccontractility in murine postischemic cardiomyopathy
-
Stull LB, Leppo MK, Szweda L, Gao WD, Marban E. Chronic treatment with allopurinol boosts survival and cardiaccontractility in murine postischemic cardiomyopathy. Circ Res 2004; 95: 1005-1011.
-
(2004)
Circ Res
, vol.95
, pp. 1005-1011
-
-
Stull, L.B.1
Leppo, M.K.2
Szweda, L.3
Gao, W.D.4
Marban, E.5
-
36
-
-
14644423890
-
NO/redox disequilibrium in the failingheart and cardiovascular system
-
Hare JM, Stamler JS. NO/redox disequilibrium in the failingheart and cardiovascular system. J Clin Invest 2005; 115:509-517.
-
(2005)
J Clin Invest
, vol.115
, pp. 509-517
-
-
Hare, J.M.1
Stamler, J.S.2
-
37
-
-
8644244680
-
Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitationcontractioncoupling
-
Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, Tejani AD, et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitationcontractioncoupling. Proc Natl Acad Sci U S A 2004; 101: 15944-15948.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 15944-15948
-
-
Khan, S.A.1
Lee, K.2
Minhas, K.M.3
Gonzalez, D.R.4
Raju, S.V.5
Tejani, A.D.6
-
38
-
-
9344267711
-
NO and superoxide: Opposite ends of the seesaw in cardiac contractility
-
Bonaventura J, Gow A. NO and superoxide: opposite ends of the seesaw in cardiac contractility. Proc Natl Acad Sci USA 2004; 101: 16403-16404.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 16403-16404
-
-
Bonaventura, J.1
Gow, A.2
-
39
-
-
0037461111
-
Uric acid and survival in chronic heartfailure: Validation and application in metabolic, functional, and hemodynamic staging
-
Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heartfailure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003; 107: 1991-1997.
-
(2003)
Circulation
, vol.107
, pp. 1991-1997
-
-
Anker, S.D.1
Doehner, W.2
Rauchhaus, M.3
Sharma, R.4
Francis, D.5
Knosalla, C.6
-
40
-
-
12344285284
-
Uric acid in chronic heart failure
-
Doehner W, Anker SD. Uric acid in chronic heart failure. Semin Nephrol 2005; 25: 61-66.
-
(2005)
Semin Nephrol
, vol.25
, pp. 61-66
-
-
Doehner, W.1
Anker, S.D.2
-
41
-
-
0032563386
-
2+_itizing property of xanthine oxidase inhibitors
-
2+_itizing property of xanthine oxidase inhibitors. Circ Res 1998; 83: 423-430.
-
(1998)
Circ Res
, vol.83
, pp. 423-430
-
-
Perez, N.G.1
Gao, W.D.2
Marban, E.3
-
42
-
-
17144396355
-
Pharmacokinetics and pharmacodynamics offebuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment
-
Mayer MD, Khosravan R, Vernillet L, Wu JT, Joseph-Ridge N, Mulford DJ. Pharmacokinetics and pharmacodynamics offebuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. Am J Ther 2005;12: 22-34.
-
(2005)
Am J Ther
, vol.12
, pp. 22-34
-
-
Mayer, M.D.1
Khosravan, R.2
Vernillet, L.3
Wu, J.T.4
Joseph-Ridge, N.5
Mulford, D.J.6
-
43
-
-
33746865996
-
Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects
-
Khosravan R, Grabowski BA, Wu JT, Joseph-Ridge N, Vernillet L. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects. Clin Pharmacokinet 2006; 45: 821-841.
-
(2006)
Clin Pharmacokinet
, vol.45
, pp. 821-841
-
-
Khosravan, R.1
Grabowski, B.A.2
Wu, J.T.3
Joseph-Ridge, N.4
Vernillet, L.5
-
44
-
-
10344260696
-
Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serumurate in healthy volunteers
-
Becker MA, Kisicki J, Khosravan R, Wu J, Mulford D, Hunt B, et al. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serumurate in healthy volunteers. Nucleosides Nucleotides NucleicAcids 2004; 23: 1111-1116.
-
(2004)
Nucleosides Nucleotides NucleicAcids
, vol.23
, pp. 1111-1116
-
-
Becker, M.A.1
Kisicki, J.2
Khosravan, R.3
Wu, J.4
Mulford, D.5
Hunt, B.6
-
45
-
-
33751200338
-
Acute effects of febuxostat, a nonpurine selective inhibitor ofxanthine oxidase, in pacing induced heart failure
-
Hou M, Hu Q, Chen Y, Zhao L, Zhang J, Bache RJ. Acute effects of febuxostat, a nonpurine selective inhibitor ofxanthine oxidase, in pacing induced heart failure. J Cardiovasc Pharmacol 2006; 5: 255-263.
-
(2006)
J Cardiovasc Pharmacol
, vol.5
, pp. 255-263
-
-
Hou, M.1
Hu, Q.2
Chen, Y.3
Zhao, L.4
Zhang, J.5
Bache, R.J.6
-
46
-
-
55149124723
-
Xanthine oxidase inhibition with febuxostat attenuates systolicoverload-induced left ventricular hypertrophy and dysfunctionin mice
-
Xu X, Hu X, Lu Z, Zhang P, Zhao L, Wessale JL, et al. Xanthine oxidase inhibition with febuxostat attenuates systolicoverload-induced left ventricular hypertrophy and dysfunctionin mice. J Card Fail 2008; 14: 746-753.
-
(2008)
J Card Fail
, vol.14
, pp. 746-753
-
-
Xu, X.1
Hu, X.2
Lu, Z.3
Zhang, P.4
Zhao, L.5
Wessale, J.L.6
-
47
-
-
41149104043
-
Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters
-
Hayashi K, Kimata H, Obata K, Matsushita A, Fukata A, Hashimoto K, et al. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters. JCard Fail 2008; 3: 238-244.
-
(2008)
JCard Fail
, vol.3
, pp. 238-244
-
-
Hayashi, K.1
Kimata, H.2
Obata, K.3
Matsushita, A.4
Fukata, A.5
Hashimoto, K.6
|